These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

152 related items for PubMed ID: 12184055

  • 1. The renin-angiotensin system in progression, remission and regression of chronic nephropathies.
    Aros C, Remuzzi G.
    J Hypertens Suppl; 2002 Jun; 20(3):S45-53. PubMed ID: 12184055
    [Abstract] [Full Text] [Related]

  • 2. Chronic renal diseases: renoprotective benefits of renin-angiotensin system inhibition.
    Remuzzi G, Ruggenenti P, Perico N.
    Ann Intern Med; 2002 Apr 16; 136(8):604-15. PubMed ID: 11955029
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Renoprotection by blockade of the renin-angiotensin-aldosterone system in diabetic and non-diabetic chronic kidney disease. Specific involvement of intra-renal angiotensin-converting enzyme activity in therapy resistance?
    Vogt L, Kocks MJ, Laverman GD, Navis G.
    Minerva Med; 2004 Oct 16; 95(5):395-409. PubMed ID: 15467515
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Therapeutic effects of angiotensin II inhibition or blockade on the progression of chronic renal disease.
    Cantarovich F, Rangoonwala B.
    Int J Clin Pract; 2003 Nov 16; 57(9):801-22. PubMed ID: 14686572
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Role of increased glomerular protein traffic in the progression of renal failure.
    Bruzzi I, Benigni A, Remuzzi G.
    Kidney Int Suppl; 1997 Nov 16; 62():S29-31. PubMed ID: 9350674
    [Abstract] [Full Text] [Related]

  • 9. Glomerular protein trafficking and progression of renal disease to terminal uremia.
    Benigni A, Remuzzi G.
    Semin Nephrol; 1996 May 16; 16(3):151-9. PubMed ID: 8734458
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Prescribing angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in chronic kidney disease.
    Ferrari P.
    Nephrology (Carlton); 2007 Feb 16; 12(1):81-9. PubMed ID: 17295666
    [Abstract] [Full Text] [Related]

  • 12. Inhibitors of the renin-angiotensin system reduce the rate of GFR decline and end-stage renal disease in patients with severe renal insufficiency.
    Pisoni R, Faraone R, Ruggenent P, Remuzzi G.
    J Nephrol; 2002 Feb 16; 15(4):428-30. PubMed ID: 12243375
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Renin-angiotensin-aldosterone system blockade and renal protection: angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers?
    Ruilope LM.
    Acta Diabetol; 2005 Apr 16; 42 Suppl 1():S33-41. PubMed ID: 15868118
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [Inhibition of the renin-angiotensin system to prevent target organ damage: the "renal continuum"].
    Tislér A.
    Orv Hetil; 2003 May 04; 144(18 Suppl 1):898-901. PubMed ID: 12785234
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.